Introduction:
Sleep Apnea & ZHT - Zhou's Hypoxicology Therapy
Sleep apnea, sleep-disordered breathing, and intermittent hypoxia
have been identified and linked in latest research to almost all
major fatal medical conditions, from heart attack, stroke, diabetes,
COPD cancer, and major depressive disorders.
What is ZHT?
Zhou’s Hypoxicology
Therapy (ZHT) was pioneered/developed by Dr. Jin
Zhou, DC, in late 2004. It is a new medical clinical concept of etiology, pathophysiology and clinical therapy, which identifies Trachea Caudal
Displacement (TCD) & Vocal Cord dysfunction (VCD) induced chronic
intermittent hypoxia through Silent Upper Airway Resistance Syndrome (SUARS)
and Frequent & Recurrent Upper Airway Collapse Syndrome (FRUACS) or
sleep-disordered breathing, as well as
nocturnal gastroesophageal reflux (NGER) as a new fundamental physio-pathological
mechanism, as one of the main causes, for mild to moderate but
prolonged hypoxia for most illness & diseases for worldwide mortality
and disability, from pain & arthritis, heart attack, hypertension,
diabetes, anxiety & depression to almost every illness & diseases.
It is now
reasonably well-known and established that sleep apnea has been
linked to most of the CDC's top 10 death-cause medical conditions,
such as heart attack, cancer, stroke and diabetes. However, the
original or ultimate cause for sleep apnea is not clearly known at
all to the scientists and health care practitioners. Dr. Jin Zhou
challenges the popular or mainstream theory in etiology for the
sleep apnea that obstruction or collapse of the upper airway is due
to the weakened and enlarged soft palate. As a matter of fact, as
Dr. Jin Zhou hypothesized, the clinical reality is the exact
opposite or completely different, therefore the current mainstream
clinical treatment protocols by surgery and CPAP or oral devices are
not expected to ultimately cure sleep apnea but simply to provide
for some limited or short-term relief or temporarily cover up the
deterioration of sleep apnea development.
In developing the new ZHT (Zhou's Hypoxicology Therapy) treatment of
sleep apnea, Dr. Zhou, observed clinically that trachea caudal
displacement (TCD) (the windpipe moving downward), resulted from
diaphragm malfunction and baroreflex dysfunction, instead of
weakened soft appellate as claimed by the mainstream scientists, is
the main anatomical pathology for snoring, collapse of the upper
airway and frequent breathing stops during the night for people with
obstructive sleep apnea. In addition, as Dr. Zhou hypothesized, the
dysfunction of the baroreflex, chemoreflex, metabo-reflex,
mechanoreflex, psychosomato-reflex and respiration pace-making
malfunction, due to psychological, environmental and anatomical
causations, are primarily and intricately responsible for the
obstructive and central sleep apnea development. Dr. Zhou further
hypothesized that all of these sleep apnea etiological components
are primarily controlled or regulated internally by the human body
but induced externally. Therefore, sleep apnea should be completely
reversible primarily through volitional resuscitation, resetting of
the baroreflex and revitalization of the upper airway defense reflex
by working through patient's body internally instead of externally
through surgeries and devices.
Current main-stream
treatment options are unsatisfactory, and the entire world is
looking for a better or best solution.
This market is one
of the most explosive and largely untapped markets.
Unlike other
therapies currently used for sleep apnea, ZHT (Zhou's hypoxicology
Therapy) identifies the root causes of sleep apnea, ZHT employs
human natural power, human systemic defense reflexes, volitional
resuscitations to eliminate and relieve not only sleep apnea but
also many other intermittent hypoxia related health problems.
Hypoxia (mild
oxygen deprivation) has been identified as the main cause of almost
every major illness. Hypoxia has been called the “Hidden and
invisible Killer”. Dr. Zhou’s Hypoxicology Therapy (ZHT) is a simple
but powerful technique. This is a revolutionary, non-surgical and
non-invasive therapy with unprecedented clinical results in less
than 5 - 20 minutes, measurable results with pulse oximeter in 5-10
minutes and many other clinical means.
ZHT provides for immediate relief without any need of equipment,
breathing device(s) and/or supplement oxygen. ZHT is not for severe
hypoxia. However, because it opens up the upper airway, it provides
powerful and fast relief for mild hypoxia, the most mysterious cause
of illness.
When the ZHT Technique is used in conjunction with standard,
conventional medical care & chiropractic therapy, it can provide
unprecedented clinical results.
Under ZHT Sleep
Apnea Protocol, a patient is expected to see definitive noticeable
results on the first visit, significant and satisfactory results
within three sessions or ZHT therapy should be discontinued.
Generally speaking, a patient with mild sleep apnea is expected to
be well-controlled or with apnea eliminated within one month,
moderate sleep apnea within two months, and severe sleep apnea
within three months or longer for some cases. ZHT Certification
Training Program is only available to healthcare providers in any
types and specialties. Dr. Zhou hopes that his ZHT sleep apnea
programs will ensure that NTSB's sleep apnea recommendations are
practically implementable for immediate public safety, and ZHT shall
only be an alternative solution in addition to standard medical
practice without any conflict.
Based currently
published research and ZHT clinical observations, ZHT may have
potential to provide therapeutic values for diabetes, cancers,
Alzheimer's disease, Amyotrophic lateral sclerosis (ALS) and many
more sleep disordered breathing (SDB) and chronic intermittent
hypoxia related major illness and diseases.
SleepApneaUSA.net, founded by Dr. Jin Zhou, relied upon the latest
research and clinically developed ZHT - Zhou's Hypoxicology Therapy
to discover a possible cure for sleep apnea and provide an
alternative care to those who can't tolerate CPAP,"sleeping mask".
         
|
